Viromed Medical AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.36	0.02	0.2	0.15	0.25
Short-Term Investments	0	0	-	-	-
Cash & Short-Term Investments	0.36	0.02	0.2	0.15	0.25
Cash Growth	1391.18%	-87.50%	29.78%	-39.04%	-
Receivables	1.12	0.14	-	-	-
Inventory	0.72	0.37	-	-	-
Prepaid Expenses	0.1	0.06	0.02	0	-
Other Current Assets	3.36	8.71	0.01	-	-
Total Current Assets	10.04	12.39	0.23	0.15	0.25
Property, Plant & Equipment	1.26	0.12	-	-	-
Long-Term Investments	-	0.01	20.1	20.1	-
Goodwill	2.47	-	-	-	-
Other Intangible Assets	0.1	0.85	-	-	-
Other Long-Term Assets	0.04	0.03	-	0	-
Total Assets	13.91	13.4	20.33	20.26	0.25
Accounts Payable	1.2	0.57	0.08	0.08	-
Accrued Expenses	0	0	-	-	-
Current Portion of Long-Term Debt	0.01	0.01	-	-	-
Current Income Taxes Payable	0.08	1.47	-	-	-
Other Current Liabilities	0.78	0.81	-	-	-
Total Current Liabilities	2.07	2.86	0.08	0.08	-
Other Long-Term Liabilities	1.37	3.32	0.27	0.09	0
Total Liabilities	3.44	6.18	0.36	0.17	0
Common Stock	21.25	20.25	20.25	20.25	0.25
Retained Earnings	-12.23	-12.92	-0.28	-0.17	-0.01
Treasury Stock	-0.04	-0.1	-	-	-
Comprehensive Income & Other	1.5	-	-	-	-
Shareholders' Equity	10.47	7.22	19.97	20.08	0.24
Total Liabilities & Equity	13.91	13.4	20.33	20.26	0.25
Total Debt	0.01	0.01	-	-	-
Net Cash (Debt)	0.36	0.01	0.2	0.15	0.25
Net Cash Growth	2637.35%	-93.35%	29.78%	-39.04%	-
Net Cash Per Share	0.02	0.00	0.01	0.01	-
Filing Date Shares Outstanding	21.25	20.25	20.25	20.25	-
Total Common Shares Outstanding	21.25	20.25	20.25	20.25	-
Working Capital	7.97	9.53	0.14	0.07	0.25
Book Value Per Share	0.49	0.36	0.99	0.99	-
Tangible Book Value	7.9	6.37	19.97	20.08	0.24
Tangible Book Value Per Share	0.37	0.31	0.99	0.99	-
Machinery	1.15	0.05	-	-	-